Evidence map›Paper›PMID 41507366›Full record

ArticleNPJ digital medicine2026

A transformer-based survival model for prediction of all-cause mortality in patients with heart failure: a multi-cohort study.

Shishir Rao, Nouman Ahmed, Gholamreza Salimi-Khorshidi, Christopher Yau, Huimin Su, Nathalie Conrad, Folkert W Asselbergs, Mark Woodward, Rod Jackson, John Gf Cleland and 1 more

Abstract read
In one paragraph

Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Shishir Rao *Nuffield Department of Women's & Reproductive Health, University of Oxford, Oxford, UK. Shishir.rao@wrh.ox.ac.uk.
Nouman Ahmed *Nuffield Department of Women's & Reproductive Health, University of Oxford, Oxford, UK.
Gholamreza Salimi-KhorshidiNuffield Department of Women's & Reproductive Health, University of Oxford, Oxford, UK.
Christopher YauNuffield Department of Women's & Reproductive Health, University of Oxford, Oxford, UK.
Huimin SuDepartment of Cardiovascular Sciences, Katholieke Universiteit Leuven, Leuven, Belgium.
Nathalie ConradNuffield Department of Women's & Reproductive Health, University of Oxford, Oxford, UK.
Folkert W AsselbergsHealth Data Research UK, London, UK.
Mark WoodwardThe George Institute for Global Health, University of New South Wales, Newtown, NSW, Australia.
Rod JacksonSchool of Population Health, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
John Gf ClelandBritish Heart Foundation Centre of Research Excellence, School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.
Kazem RahimiNuffield Department of Women's & Reproductive Health, University of Oxford, Oxford, UK. kazem.rahimi@wrh.ox.ac.uk.

Funding

HORIZON EUROPE European Innovation Council 101080430
6 · The paper itself

Abstract

Heart failure (HF) patients have complex health profiles that existing risk models fail to capture. We developed TRisk, a Transformer-based artificial intelligence survival model for predicting mortality using routine electronic health records (EHR) in HF patients. Using UK data from 403,534 HF patients across 1418 English general practices, we trained and validated TRisk and compared it against MAGGIC-EHR, the MAGGIC model adapted for use on routine EHR by substituting variables (e.g. left-ventricular ejection fraction) that are not routinely available. External validation was conducted on 21,767 patients from USA hospitals. In the UK cohort, TRisk achieved a concordance index (C-index): 0.845 (95% CI: 0.841, 0.849), outperforming MAGGIC-EHR (C-index: 0.728 [0.723, 0.733]) for 36-month mortality prediction. In subgroup analyses, TRisk demonstrated less variability in predictive performance by sex, age, and baseline characteristics compared to MAGGIC-EHR, suggesting less biased modelling. Evaluating TRisk in USA data via transfer learning yielded a C-index of 0.802 (0.789, 0.816). Explainability analysis revealed TRisk captured established risk factors while identifying underappreciated ones, particularly cancers and hepatic failure, with cancers maintaining prognostic utility even a decade before baseline. TRisk provides more accurate, well-calibrated mortality prediction using routine data across international healthcare settings, demonstrating potential for improved risk stratification in patients with HF.

Identifiers

PMID41507366
PMCPMC12868603

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.